In a meta-analysis of three cohort studies that evaluated the relatives of A-T patients, the estimated relative risk of breast cancer was 2.8 (90% confidence interval (CI), 2.2–3.7; p < 0.0001) for ATM PV carriers [87]. This evidence concerns the gene ATM and breast cancer.